Alembic's Q1 FY 2026-27 Quarterly Results
- 12 Aug 2026
Result Summary
- Alembic Ltd reported a 12.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 2.6%.
- Its expenses for the quarter were down by 14.6% QoQ and up 11.4% YoY.
- The net profit decreased 3.3% QoQ and increased 5.3% YoY.
- The earnings per share (EPS) of Alembic Ltd stood at 2.53 during Q1 FY 2026-27.
Financial Statments for Q1 FY 2026-27
(₹ crores) | Q1FY27 | Q4FY26 | Q1FY26 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 54.71 | 62.18 | 53.34 | -12.0% | 2.6% |
Total Expenses | 37.37 | 43.74 | 33.54 | -14.6% | 11.4% |
Profit Before Tax | 17.34 | 18.44 | 19.80 | -6.0% | -12.4% |
Tax | 1.64 | 8.83 | 1.99 | -81.4% | -17.6% |
Profit After Tax | 64.89 | 67.13 | 61.65 | -3.3% | 5.3% |
Earnings Per Share | 2.53 | 2.61 | 2.40 | -3.1% | 5.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Alembic Ltd is a company primarily engaged in the pharmaceutical industry, known for its development, manufacture, and marketing of pharmaceutical products. The company offers a range of products and services, including active pharmaceutical ingredients (APIs) and generics. Alembic Ltd has a long-standing presence in the industry, with a focus on quality and innovation. Recent developments or specific strategic changes within the company are not provided in the data, hence are not available for this analysis.
Revenue
In Q1FY27, Alembic Ltd reported total income of ₹54.71 crores, reflecting a decrease of 12.0% quarter-over-quarter (QoQ) from ₹62.18 crores in Q4FY26. However, there was a year-over-year (YoY) increase of 2.6% from ₹53.34 crores in Q1FY26. This indicates a slight improvement in revenue performance on an annual basis, despite the quarterly decline. The company's revenue dynamics appear influenced by various market factors, though specific drivers are not detailed in the provided data.
Profitability
The Profit Before Tax (PBT) for Q1FY27 was ₹17.34 crores, a 6.0% decline from the previous quarter's ₹18.44 crores and a 12.4% decrease YoY from ₹19.80 crores in Q1FY26. Tax expenses for Q1FY27 were significantly lower at ₹1.64 crores compared to ₹8.83 crores in Q4FY26, marking an 81.4% reduction QoQ, and also decreasing by 17.6% YoY from ₹1.99 crores in Q1FY26. The Profit After Tax (PAT) stood at ₹64.89 crores in Q1FY27, down 3.3% from ₹67.13 crores QoQ, but up 5.3% YoY from ₹61.65 crores. The Earnings Per Share (EPS) was ₹2.53, showing a slight decrease of 3.1% QoQ from ₹2.61, but an increase of 5.4% YoY from ₹2.40 in Q1FY26.
Operating Metrics
Total expenses for Alembic Ltd in Q1FY27 amounted to ₹37.37 crores, which was a 14.6% reduction from the previous quarter's ₹43.74 crores. However, compared to Q1FY26, expenses increased by 11.4% from ₹33.54 crores. The reduction in total expenses QoQ is noteworthy against the backdrop of a marginal increase in revenue YoY. This dynamic could impact operating efficiencies, though the data does not provide detailed operational metrics or cost breakdowns to assess specific areas of expense management.
FAQs
Alembic Ltd announced its Q1 FY 2026-27 results on 12 August, 2026.
Alembic Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Alembic Ltd Q1 FY 2026-27 results include:
- Revenue: ₹54.71 crore
- Net Profit: ₹64.89 crore
- EBITDA: ₹21.42 crore
- Year-over-Year Growth: 2.6%
- Quarter-over-Quarter Growth: -12.0%
Alembic Ltd reported a net loss of ₹64.89 crore in Q1 FY 2026-27, reflecting a 5.3% year-over-year growth.
Alembic Ltd posted a revenue of ₹54.71 crore in Q1 FY 2026-27.